News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Brookfield will acquire Aypa Power from Blackstone for $7 billion, adding ~6.5 GW operating/contracted capacity and a 20+ GW development pipeline.
  • Home BancShares raised its quarterly dividend 9.5% to $0.23 per share, payable September 2.
  • First Choice and Westin agreed to combine into Wellgevity 360 in a deal valuing the business at about $650 million enterprise value.
  • Steakholder Foods will change its ADS ratio to one ADS per 12,000 ordinary shares, a one-for-three reverse split, with no shareholder action.
  • RTB Digital's Roundtable launched an AI/DeFi enterprise media platform in London, including Coinbase integration to support journalism monetization.
  • Supernus will release second-quarter 2026 results after market close on August 4 and host a conference call and webcast.
  • Cenovus will publish second-quarter 2026 financial and operating results on July 29, followed by an analyst conference call.

Latest Articles

ENvue Medical Appoints Chairman of the Board and New Directors, Bringing Clinical, AI Governance and Capital Markets Expertise to Navigation Platform

ENvue Medical Appoints Chairman of the Board and New Directors, Bringing Clinical, AI Governance and Capital Markets Expertise to Navigation Platform

ENvue Medical has appointed Dr. Zeev Rotstein as Chairman of the Board and added Zvi Joseph and Lior Buchman as new directors, bringing extensive expertise in healthcare leadership, AI governance, and capital markets. These strategic board changes support ENvue's momentum in advancing its real-time guided bedside feeding tube placement technology a…

UroGen Receives New U.S. Patent Allowance Expected to Provide Protection into July 2044 for ZUSDURI™ and UGN-103

UroGen Receives New U.S. Patent Allowance Expected to Provide Protection into July 2044 for ZUSDURI™ and UGN-103

UroGen Pharma Ltd. announced the receipt of a U.S. patent allowance for methods treating low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC) using its proprietary RTGel technology delivering mitomycin. The patent protection is expected to extend until July 2044, reinforcing the intellectual property foundation for its FDA-a…

Cardiff Oncology Announces $10 Million Registered Direct Offering

Cardiff Oncology Announces $10 Million Registered Direct Offering

Cardiff Oncology, a clinical-stage biotech company focused on PLK1 inhibition for cancer treatment, has entered into definitive agreements for a $10 million registered direct offering of common shares and warrants. The proceeds will be primarily used for working capital and general corporate purposes to support ongoing clinical trials, especially o…

Youxin Technology Signs Cooperation Intention Agreement to Join Guangzhou's Citywide Government AI Hub Initiative “SuiZhiZheng” as an Ecosystem Partner

Youxin Technology Signs Cooperation Intention Agreement to Join Guangzhou's Citywide Government AI Hub Initiative “SuiZhiZheng” as an Ecosystem Partner

Youxin Technology Ltd announced that its subsidiary has signed a cooperation intention agreement to join Guangzhou's citywide government AI platform initiative, SuiZhiZheng. This marks the company's potential expansion from retail digital transformation services into government AI applications, leveraging its expertise in data governance and automa…

Rani Therapeutics Announces Positive Initial Phase 1a Data for RT-114 for the Treatment of Obesity, with Oral Bioavailability Exceeding Matched Subcutaneous Dosing

Rani Therapeutics Announces Positive Initial Phase 1a Data for RT-114 for the Treatment of Obesity, with Oral Bioavailability Exceeding Matched Subcutaneous Dosing

Rani Therapeutics announced positive initial results from its Phase 1a clinical trial of RT-114, an orally administered GLP-1/GLP-2 dual agonist for obesity treatment delivered via their RaniPill® Capsule. The oral dose achieved over 150% systemic exposure compared to a matched subcutaneous injection, with no serious adverse events and mild treatme…

AFC Commits $7 Million to a Senior Credit Facility

AFC Commits $7 Million to a Senior Credit Facility

Advanced Flower Capital Inc. (Nasdaq: AFCG) has committed $7 million to a $25 million senior secured credit facility aimed at refinancing existing capital and supporting growth through acquisitions in a leading outpatient behavioral health platform. The credit facility has a four-year term, is secured by all assets of the borrower, and demonstrates…

Top KingWin Ltd. Announces Trading Ticker Symbol Change to “DPU”

Top KingWin Ltd. Announces Trading Ticker Symbol Change to “DPU”

Top KingWin Ltd., a Cayman Islands holding company operating in China and the U.S., announced that effective July 16, 2026, its Class A ordinary shares will trade under the new ticker symbol 'DPU' on the Nasdaq Capital Market, replacing the previous symbol 'WAI'. No shareholder action is required, and the CUSIP number remains unchanged. The company…

Anthony Petrazzuoli Joins Provident Bank as Senior Vice President, Deposit & Payments Operations Director

Anthony Petrazzuoli Joins Provident Bank as Senior Vice President, Deposit & Payments Operations Director

Provident Bank has announced the hiring of Anthony Petrazzuoli as Senior Vice President, Deposit & Payments Operations Director. Bringing over 25 years of banking experience, Petrazzuoli will oversee deposit and payment operations to enhance customer experience, regulatory compliance, and strategic initiatives supporting the bank's growth. His prio…

Sunrun Announces Date for Second Quarter 2026 Earnings Report

Sunrun Announces Date for Second Quarter 2026 Earnings Report

Sunrun Inc., a leading US provider of home solar and battery storage solutions, announced that it will release its second quarter 2026 earnings report after market close on August 5, 2026, followed by a conference call to discuss the results. The company offers home energy systems with a no-upfront-cost subscription model and contributes to grid st…